Analyst consensus rating
Edesa Biotech Analyst Rating: Strong Buy
Direct answer
Edesa Biotech's consensus rating is Strong Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $16.33.
Forecast evidence checked November 12, 2026.
Get free Edesa Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.22
- Average price target
- $16.33
- High price target
- $21.00
- Low price target
- $9.00
- Low target gap
- +305.4%
- Target upside
- +635.7%
- High target gap
- +845.9%
- Target range width
- 540.5%
- Consensus rating
- Strong Buy
- Analysts
- 3
- Evidence date
- November 12, 2026
- Valid through
- November 19, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Edesa Biotech?
Edesa Biotech has a verified Strong Buy consensus. The same dataset has an average price target of $16.33.
How far are Edesa Biotech's low and high targets from the recorded price?
The low target implies +305.4%, while the high target implies +845.9%.
How many analysts are included in Edesa Biotech's consensus?
The verified consensus includes 3 analysts.
How is Edesa Biotech's target upside or downside calculated?
The average target of $16.33 is divided by the recorded price of $2.22, then one is subtracted to produce +635.7%. This does not guarantee a future return.
When was Edesa Biotech's analyst forecast verified?
The data was verified on 2026-11-12. The dataset is valid through 2026-11-19.